Eye Tracking-Based Diagnosis and Early Detection of Autism Spectrum Disorder Using Machine Learning and Deep Learning Techniques

Eye tracking is a useful technique for detecting autism spectrum disorder (ASD). One of the most important aspects of good learning is the ability to have atypical visual attention. The eye-tracking technique provides useful information about children’s visual behaviour for early and accurate diagnosis. It works by scanning the paths of the eyes to extract a sequence of eye projection points on the image to analyse the behaviour of children with autism. In this study, three artificial-intelligence techniques were developed, namely, machine learning, deep learning, and a hybrid technique between them, for early diagnosis of autism. The first technique, neural networks [feedforward neural networks (FFNNs) and artificial neural networks (ANNs)], is based on feature classification extracted by a hybrid method between local binary pattern (LBP) and grey level co-occurrence matrix (GLCM) algorithms. This technique achieved a high accuracy of 99.8% for FFNNs and ANNs. The second technique used a pre-trained convolutional neural network (CNN) model, such as GoogleNet and ResNet-18, on the basis of deep feature map extraction. The GoogleNet and ResNet-18 models achieved high performances of 93.6% and 97.6%, respectively. The third technique used the hybrid method between deep learning (GoogleNet and ResNet-18) and machine learning (SVM), called GoogleNet + SVM and ResNet-18 + SVM. This technique depends on two blocks. The first block used CNN to extract deep feature maps, whilst the second block used SVM to classify the features extracted from the first block. This technique proved its high diagnostic ability, achieving accuracies of 95.5% and 94.5% for GoogleNet + SVM and ResNet-18 + SVM, respectively

Multi-method analysis of medical records and mri images for early diagnosis of dementia and alzheimer’s disease based on deep learning and hybrid methods

Dementia and Alzheimer’s disease are caused by neurodegeneration and poor commu-nication between neurons in the brain. So far, no effective medications have been discovered for dementia and Alzheimer’s disease. Thus, early diagnosis is necessary to avoid the development of these diseases. In this study, efficient machine learning algorithms were assessed to evaluate the Open Access Series of Imaging Studies (OASIS) dataset for dementia diagnosis. Two CNN models (AlexNet and ResNet-50) and hybrid techniques between deep learning and machine learning (AlexNet+SVM and ResNet-50+SVM) were also evaluated for the diagnosis of Alzheimer’s disease. For the OASIS dataset, we balanced the dataset, replaced the missing values, and applied the t-Distributed Stochastic Neighbour Embedding algorithm (t-SNE) to represent the high-dimensional data in the low-dimensional space. All of the machine learning algorithms, namely, Support Vector Machine (SVM), Decision Tree, Random Forest and K Nearest Neighbours (KNN), achieved high performance for diagnosing dementia. The random forest algorithm achieved an overall accuracy of 94% and precision, recall and F1 scores of 93%, 98% and 96%, respectively. The second dataset, the MRI image dataset, was evaluated by AlexNet and ResNet-50 models and AlexNet+SVM and ResNet-50+SVM hybrid techniques. All models achieved high performance, but the performance of the hybrid methods between deep learning and machine learning was better than that of the deep learning models. The AlexNet+SVM hybrid model achieved accuracy, sensitivity, specificity and AUC scores of 94.8%, 93%, 97.75% and 99.70%, respectively

Deep Learning and Machine Learning for Early Detection of Stroke and Haemorrhage

Stroke and cerebral haemorrhage are the second leading causes of death in the world after ischaemic heart disease. In this work, a dataset containing medical, physiological and environmental tests for stroke was used to evaluate the efficacy of machine learning, deep learning and a hybrid technique between deep learning and machine learning on theMagnetic Resonance Imaging (MRI) dataset for cerebral haemorrhage. In the first dataset (medical records), two features, namely, diabetes and obesity, were created on the basis of the values of the corresponding features. The t-Distributed Stochastic Neighbour Embedding algorithm was applied to represent the high-dimensional dataset in a low-dimensional data space. Meanwhile, the Recursive Feature Elimination algorithm (RFE) was applied to rank the features according to priority and their correlation to the target feature and to remove the unimportant features. The features are fed into the various classification algorithms, namely, Support Vector Machine (SVM), K Nearest Neighbours (KNN), Decision Tree, Random Forest, and Multilayer Perceptron. All algorithms achieved superior results. The Random Forest algorithm achieved the best performance amongst the algorithms; it reached an overall accuracy of 99%. This algorithm classified stroke cases with Precision, Recall and F1 score of 98%, 100% and 99%, respectively. In the second dataset, the MRI image dataset was evaluated by using the AlexNet model and AlexNet+SVM hybrid technique. The hybrid model AlexNet+SVM performed is better than the AlexNet model; it reached accuracy, sensitivity, specificity and Area Under the Curve (AUC) of 99.9%, 100%, 99.80% and 99.86%, respectively

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362